Colon Cancer Misdiagnosis Lawsuits in New York
When colon cancer is missed on colonoscopy, attributed to hemorrhoids without evaluation, or misread by a pathologist, a curable disease can become a terminal one. Learn how diagnostic errors constitute medical malpractice under New York law.
Looking for a New York medical malpractice lawyer? Our team handles cases just like this across New York.
Colon Cancer Misdiagnosis in New York
Colorectal cancer is the third most commonly diagnosed cancer in the United States, with approximately 150,000 new cases each year. When caught early, colon cancer is highly treatable — the 5-year survival rate for localized colon cancer is 91%. But when diagnosis is delayed, the cancer spreads, and survival rates drop dramatically — to 72% for regional spread and 14% for distant metastasis.
For patients in New York who have been affected by colon cancer misdiagnosis, the question is often not whether the cancer could have been treated — but whether a doctor's negligence delayed the diagnosis and allowed the cancer to progress. A colon cancer misdiagnosis attorney can help answer this question by reviewing colonoscopy reports, pathology slides, lab results, and medical records to determine whether the standard of care was met.
At MDLaw Firm, our New York medical malpractice attorneys understand both the medical complexity of colon cancer diagnosis and the legal standards that govern gastroenterology, pathology, and oncology. We work with board-certified gastroenterologists, pathologists, and oncologists to evaluate whether your colon cancer was misdiagnosed due to negligence — and whether earlier diagnosis would have changed your outcome.
How Colon Cancer Is Diagnosed
Colon cancer diagnosis involves screening, diagnostic testing, and tissue biopsy:
- Screening colonoscopy: The gold standard for colon cancer screening. A gastroenterologist examines the entire colon with a flexible camera, looking for polyps (precancerous growths) and tumors. Polyps can be removed during the procedure, preventing cancer from developing. Screening is recommended starting at age 45 (or earlier for high-risk patients).
- Fecal occult blood test (FOBT) or fecal immunochemical test (FIT): Non-invasive tests that detect blood in the stool, a potential sign of colon cancer. Positive results require follow-up colonoscopy.
- CT colonography (virtual colonoscopy): A CT scan that creates images of the colon. Less invasive than traditional colonoscopy but less sensitive for small polyps, and any abnormal finding requires traditional colonoscopy for biopsy.
- Diagnostic colonoscopy: Performed when a patient has symptoms (rectal bleeding, change in bowel habits, abdominal pain) or an abnormal screening test. The gastroenterologist identifies suspicious areas and takes biopsies.
- Biopsy and pathology: Tissue samples taken during colonoscopy are examined by a pathologist under a microscope. The pathologist determines whether cancer is present, the type (adenocarcinoma is most common), the grade (how aggressive it appears), and the depth of invasion.
- Imaging for staging: CT scan of the chest, abdomen, and pelvis to determine whether the cancer has spread to lymph nodes or distant organs. MRI may be used for rectal cancer.
- CEA (carcinoembryonic antigen) blood test: A tumor marker used to monitor treatment response and detect recurrence.
Common Ways Colon Cancer Is Misdiagnosed
Colon cancer misdiagnosis can occur at any point in the diagnostic process:
- Attributing symptoms to a less serious condition: Rectal bleeding, change in bowel habits, and abdominal pain are often attributed to hemorrhoids, irritable bowel syndrome (IBS), or inflammatory bowel disease (IBD) without appropriate evaluation. Hemorrhoids are the most common misdiagnosis — a patient with rectal bleeding is told it is just hemorrhoids, without a colonoscopy to rule out cancer.
- Failure to perform colonoscopy: When a patient presents with symptoms concerning for colon cancer (rectal bleeding, change in bowel habits, unexplained weight loss, abdominal pain), the standard of care requires colonoscopy. Failure to perform colonoscopy may constitute negligence.
- Incomplete colonoscopy: The gastroenterologist does not reach the cecum (the end of the colon), missing tumors in the right colon. Inadequate bowel preparation can also obscure tumors.
- Failure to identify or remove polyps: During colonoscopy, the gastroenterologist should identify and remove all visible polyps. Failure to identify polyps — particularly large or suspicious ones — allows them to grow and potentially become cancerous.
- Failure to biopsy suspicious lesions: When a suspicious area is seen during colonoscopy, the standard of care requires biopsy. Failure to biopsy may constitute negligence.
- Pathology errors: The pathologist misinterprets the biopsy tissue — diagnosing cancer when it is not present (false positive) or missing cancer that is present (false negative). Pathology errors can also involve misclassifying the type or grade of cancer, leading to inappropriate treatment.
- Failure to communicate or follow up: Abnormal results are not communicated to the patient or referring physician, or follow-up appointments are not arranged. The cancer goes untreated.
- Failure to screen: A primary care physician fails to recommend screening colonoscopy at the appropriate age (45 for average-risk patients, earlier for high-risk patients), allowing a preventable cancer to develop undetected.
Screening and the Standard of Care
The standard of care for colon cancer screening in New York includes:
- Screening starting at age 45 for average-risk patients (updated from age 50 in response to rising rates of colon cancer in younger adults). High-risk patients (family history, inflammatory bowel disease, genetic syndromes) should begin screening earlier and more frequently. - Colonoscopy every 10 years for average-risk patients with normal results. - FIT or FOBT annually as an alternative to colonoscopy, with colonoscopy required for any positive result. - Symptomatic patients: Any patient with symptoms concerning for colon cancer (rectal bleeding, change in bowel habits, unexplained weight loss, abdominal pain, anemia) should undergo diagnostic colonoscopy — regardless of age or screening status. - Surveillance colonoscopy: Patients with a history of polyps or colon cancer require more frequent surveillance colonoscopy.
Failure to recommend screening at the appropriate age, or failure to perform colonoscopy in a symptomatic patient, may constitute negligence.
Colonoscopy Errors
Colonoscopy is the primary tool for colon cancer diagnosis and prevention, but errors can occur:
- Incomplete examination: The gastroenterologist does not reach the cecum, missing tumors — particularly in the right colon, where cancers are harder to detect. The cecal intubation rate (percentage of procedures reaching the cecum) should be at least 90% in screening colonoscopies. - Inadequate bowel preparation: If the patient's bowel is not adequately cleaned, polyps and tumors may be obscured. The gastroenterologist should reschedule the procedure if preparation is inadequate, rather than proceeding with a suboptimal examination. - Low adenoma detection rate (ADR): The ADR is the percentage of screening colonoscopies in which at least one adenomatous polyp is found. A low ADR suggests that the gastroenterologist is missing polyps. The standard ADR should be at least 25-30% for men and 15-20% for women. - Failure to remove polyps: All visible polyps should be removed during colonoscopy. Failure to remove polyps allows them to grow and potentially become cancerous. - Complications: Perforation of the colon and bleeding are known risks of colonoscopy. Failure to recognize and treat these complications promptly may constitute negligence. [Link to: /surgical-errors/laparoscopic-bowel-perforation] - Failure to recommend appropriate surveillance: Patients with high-risk polyps (large, villous, or with high-grade dysplasia) require more frequent surveillance colonoscopy.
Pathology Errors in Colon Cancer
Pathology errors are a less common but devastating cause of colon cancer misdiagnosis:
- False negative: The pathologist misses cancer that is present in the biopsy tissue. The patient is told the polyp is benign, and the cancer goes untreated. - False positive: The pathologist diagnoses cancer when it is not present, leading to unnecessary surgery and treatment. - Misclassification: The pathologist misclassifies the type or grade of cancer, leading to inappropriate treatment. For example, misclassifying a high-grade (aggressive) cancer as low-grade may result in undertreatment. - Failure to assess depth of invasion: The depth of tumor invasion into the bowel wall determines the stage and treatment. Failure to accurately assess invasion may lead to inappropriate treatment. - Failure to test for molecular markers: Certain genetic markers (KRAS, NRAS, BRAF, MSI status) guide treatment decisions, particularly for metastatic colon cancer. Failure to test for these markers may result in inappropriate treatment.
An independent pathologist should review the slides in any case of suspected pathology error.
When Colon Cancer Misdiagnosis Constitutes Malpractice
Colon cancer misdiagnosis constitutes medical malpractice when a healthcare provider deviated from the standard of care and that deviation caused harm. This includes:
- Failure to screen: A primary care physician failed to recommend screening colonoscopy at the appropriate age.
- Failure to perform colonoscopy in a symptomatic patient: A patient with rectal bleeding or change in bowel habits was not referred for colonoscopy.
- Misdiagnosis of symptoms: Rectal bleeding was attributed to hemorrhoids without colonoscopy to rule out cancer.
- Colonoscopy errors: Incomplete examination, failure to identify polyps, failure to biopsy suspicious lesions, or inadequate bowel preparation obscuring tumors.
- Pathology errors: The pathologist missed cancer, misclassified the type or grade, or failed to test for molecular markers.
- Failure to communicate or follow up: Abnormal results were not communicated, or follow-up was not arranged.
- Failure to recommend appropriate surveillance: Patients with high-risk polyps or a history of colon cancer require more frequent surveillance.
The Impact of Delayed Colon Cancer Diagnosis
The impact of a delayed colon cancer diagnosis can be devastating:
- Stage progression: A cancer that could have been diagnosed at stage 1 (5-year survival: 91%) may progress to stage 3 or 4 (5-year survival: 14%) due to delayed diagnosis. - More aggressive treatment: Later-stage cancer requires more aggressive treatment — surgery with chemotherapy, radiation (for rectal cancer), and targeted therapies. - Spread to lymph nodes and distant organs: Cancer that has spread to lymph nodes or distant organs (liver, lungs) is much harder to treat and significantly reduces survival. - Need for permanent colostomy: Advanced rectal cancer may require a permanent colostomy.", - Reduced survival: The most devastating consequence. A patient who could have been cured may face a terminal diagnosis.", - Physical and emotional toll: More aggressive treatment causes more side effects — nausea, fatigue, neuropathy, diarrhea, and emotional trauma.
Lavern's Law and Your Deadline to File
Colon cancer misdiagnosis cases in New York are subject to Lavern's Law, which provides a discovery rule for cancer cases. Under Lavern's Law:
- You have 2.5 years from the date you discovered (or should have discovered) the misdiagnosis to file a lawsuit. - There is an absolute outer limit of 7 years from the date of the negligent act.
This means that even if years have passed since the misdiagnosis, you may still have a valid claim if you discovered the error recently. For example, if you were diagnosed with advanced colon cancer in 2024 and discovered in 2025 that a gastroenterologist missed a tumor on a 2021 colonoscopy, you would have 2.5 years from the date of discovery to file.
Lavern's Law applies only to cancer cases. [Link to: /misdiagnosis/laverns-law]
Frequently Asked Questions
How is colon cancer diagnosed?
Colon cancer is diagnosed through screening colonoscopy (the gold standard), fecal occult blood tests (FOBT/FIT), CT colonography, and diagnostic colonoscopy for symptomatic patients. During colonoscopy, the gastroenterologist identifies suspicious areas and takes biopsies. A pathologist examines the tissue under a microscope to determine whether cancer is present, the type, grade, and depth of invasion. Imaging (CT, MRI) is used for staging.
What is the most common way colon cancer is misdiagnosed?
The most common misdiagnosis is attributing rectal bleeding to hemorrhoids without performing a colonoscopy to rule out cancer. Other common errors include failure to perform colonoscopy in symptomatic patients, incomplete colonoscopy (not reaching the cecum), failure to identify or remove polyps, pathology errors (missing cancer in biopsy tissue), and failure to communicate or follow up on abnormal results.
At what age should colon cancer screening begin?
Screening colonoscopy should begin at age 45 for average-risk patients (updated from age 50 in response to rising rates of colon cancer in younger adults). High-risk patients — those with a family history of colon cancer, inflammatory bowel disease, or genetic syndromes (FAP, Lynch syndrome) — should begin screening earlier and more frequently. Any patient with symptoms concerning for colon cancer (rectal bleeding, change in bowel habits, unexplained weight loss, abdominal pain, anemia) should undergo diagnostic colonoscopy regardless of age.
When does colon cancer misdiagnosis constitute medical malpractice?
Colon cancer misdiagnosis constitutes malpractice when a healthcare provider deviated from the standard of care — by failing to recommend screening, failing to perform colonoscopy in a symptomatic patient, attributing symptoms to hemorrhoids without colonoscopy, performing an incomplete colonoscopy, failing to identify or biopsy polyps, making pathology errors, or failing to communicate or follow up — and that deviation caused harm (e.g., the cancer progressed to a more advanced stage).
What is an adenoma detection rate (ADR)?
The adenoma detection rate (ADR) is the percentage of screening colonoscopies in which at least one adenomatous polyp (a precancerous growth) is found. A low ADR suggests that the gastroenterologist is missing polyps. The standard ADR should be at least 25-30% for men and 15-20% for women. A gastroenterologist with a consistently low ADR may be breaching the standard of care.
How does Lavern's Law apply to colon cancer misdiagnosis cases?
Lavern's Law provides a discovery rule for cancer cases in New York. You have 2.5 years from the date you discovered (or should have discovered) the misdiagnosis to file a lawsuit, subject to a 7-year outer limit from the date of the negligent act. This means that even if years have passed since the misdiagnosis, you may still have a valid claim if you discovered the error recently.
What is the survival rate for colon cancer?
The 5-year survival rate for localized colon cancer (stage 1) is 91%. For regional spread (stage 3, spread to nearby lymph nodes), it drops to 72%. For distant metastasis (stage 4, spread to distant organs like the liver or lungs), the 5-year survival rate is only 14%. This is why early diagnosis is critical — and why delayed diagnosis is so devastating.
How Much Is My Colon Cancer Misdiagnosis Lawsuits in New York Case Worth?
The value of a medical malpractice case in New York depends on several factors, including the severity of the injury, the strength of liability evidence, and the economic and non-economic damages involved. New York is one of the few states with no caps on medical malpractice damages, meaning there is no artificial limit on what you can recover. Below are typical settlement ranges based on injury severity.
Catastrophic Injury (Brain Damage, Cerebral Palsy, Quadriplegia)
$5,000,000 - $50,000,000+Key Factors
- Lifetime care needs (often $10M+)
- Loss of future earnings
- Pain and suffering
- Medical equipment and home modifications
- 24/7 nursing care
Examples
- Birth injury resulting in cerebral palsy
- Anesthesia hypoxic brain injury
- Surgical error causing paralysis
Wrongful Death
$1,000,000 - $15,000,000Key Factors
- Decedent's age and earning capacity
- Pecuniary loss to distributees (EPTL 5-4.1)
- Conscious pain and suffering before death
- Loss of parental guidance
- Medical and funeral expenses
Examples
- Failure to diagnose cancer leading to death
- Surgical error causing fatal hemorrhage
- Delayed sepsis treatment
Significant Permanent Injury
$500,000 - $5,000,000Key Factors
- Permanent partial disability
- Future medical expenses
- Lost wages and diminished earning capacity
- Pain and suffering
- Impact on quality of life
Examples
- Wrong-site surgery
- Nerve damage from surgical error
- Delayed stroke diagnosis causing permanent deficit
Serious but Non-Permanent Injury
$250,000 - $1,000,000Key Factors
- Temporary disability
- Medical expenses
- Lost wages during recovery
- Pain and suffering
- Emotional distress
Examples
- Surgical site infection
- Medication error requiring prolonged hospitalization
- Delayed fracture diagnosis
Factors That Affect Your Settlement
Severity of Injury
More severe and permanent injuries command higher settlements due to lifetime care costs.
Liability Strength
Clear negligence (e.g., retained surgical object) yields higher offers than contested liability.
Economic Damages
Medical bills, lost wages, and future care costs are quantifiable and form the settlement floor.
Non-Economic Damages
Pain and suffering, loss of enjoyment of life, and emotional distress vary by injury type.
NY Statutory Caps
New York has NO caps on medical malpractice damages, unlike many other states — allowing for full compensation.
Medical Indemnity Fund (MIF)
Birth-related neurological injuries may qualify for the NY MIF, providing lifetime medical coverage.
Comparative Negligence
If the plaintiff is partially at fault, the settlement is reduced by their percentage of fault (CPLR 1411).
Defendant Resources
Hospital systems and their insurers typically have higher policy limits than individual providers.
Frequently Asked Questions
What is the average medical malpractice settlement in New York?
The average medical malpractice settlement in New York varies widely by injury type, but typically ranges from $500,000 to $5,000,000 for significant injuries. Catastrophic injuries such as cerebral palsy or brain damage can exceed $10,000,000. New York has no caps on damages, so there is no artificial ceiling on compensation.
How long does a medical malpractice case take in New York?
Most medical malpractice cases in New York take 18-36 months from filing to resolution. Complex cases involving multiple defendants or novel legal issues can take 3-5 years. Cases that settle before trial typically resolve faster, while cases that go to verdict can take significantly longer.
What percentage do medical malpractice lawyers take in NY?
New York medical malpractice attorneys typically work on a contingency fee basis, meaning you pay nothing upfront. The standard fee is 30% of the recovery, though it may vary by case complexity and stage of resolution. The fee must be approved by the court.
Are medical malpractice settlements taxable in New York?
Compensation for physical injuries and medical expenses is generally not taxable under federal and New York tax law. However, portions allocated to lost wages or punitive damages may be taxable. Consult a tax professional for guidance on your specific settlement.
What if I was partially at fault for my injury?
New York follows comparative negligence (CPLR 1411), meaning your settlement is reduced by your percentage of fault. For example, if you are found 20% at fault and the total damages are $1,000,000, you would recover $800,000. You can recover compensation as long as you are not 100% at fault.
Get a Personalized Case Valuation
Every case is unique. Our attorneys can evaluate the specific facts of your situation and provide an estimated range of compensation. This consultation is free and confidential.
Local Coverage
MDLaw Firm handles medical malpractice cases across New York City and the broader metro area. Find borough-specific resources and deadlines:
Get the Help Your Family Deserves
If you or a loved one has been affected by colon cancer misdiagnosis in New York, contact MDLaw Firm at 347-524-5777 for a free consultation. Even if years have passed, Lavern's Law may give you more time than you think.
Looking for a local attorney? See our NYC Medical Malpractice Lawyer page for borough-specific representation.
This article is for informational purposes only and does not constitute legal advice. Prior results do not guarantee a similar outcome. No attorney-client relationship is created by reading this article or contacting MDLaw Firm.
Misdiagnosis Resources
- Lavern's Law
- Pulmonary Embolism
- Meningitis
- Failure to Diagnose vs. Misdiagnosis
- Breast Cancer
- Appendicitis
- Colon Cancer
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Cervical Cancer
- Leukemia & Lymphoma
- Pathology Biopsy Errors
- Pediatric Misdiagnosis
- Aortic Dissection
- Differential Diagnosis
- Big Three Errors
- NY Statistics
- Settlement Guide
- Loss of Chance
Expertise by Injury Type
Free Case Review
If you or a loved one has been affected by colon cancer misdiagnosis in New York, contact MDLaw Firm at 347-524-5777 for a free consultation. Even if years have passed, Lavern's Law may give you more time than you think.
Start Your ReviewNo fees. No commitments. Confidential.
Key Facts
- Stage 1 survival: 91%; Stage 4 survival: 14%
- Screening colonoscopy should start at age 45
- Hemorrhoids are the most common misdiagnosis
- ADR (adenoma detection rate) should be at least 25-30% (men)
- Lavern's Law: 2.5 years from discovery, 7-year outer limit
- NY does not cap non-economic damages
Related Pages
The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by reading this page or submitting a contact form.